The Misuse of Drugs (Amendment) Regulations 2006 © Crown Copyright 2006 Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament. The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users. It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document. The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Misuse of Drugs (Amendment) Regulations 2006, ISBN 0110744403. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail: customer.services@tso.co.uk. Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions. To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
The Secretary of State makes the following regulations in exercise of the powers conferred by sections 7(1) and (2), 10, 22 and 31(1) of the Misuse of Drugs Act 1971[1]. In accordance with section 31(3) of that Act he has consulted with the Advisory Council on the Misuse of Drugs. Citation, commencement and interpretation 1. —(1) These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2006 and shall come into force on 1st May 2006. (2) In these Regulations, "the 2001 Regulations" means the Misuse of Drugs Regulations 2001[2]. Amendment of regulation 2 of the 2001 Regulations 2. In regulation 2 of the 2001 Regulations (interpretation), in paragraph (1)—
(b) after the definition of "medicinal product" insert the following definition—
Amendment of regulation 6B of the 2001 Regulations
(b) for "An extended formulary nurse prescriber" substitute "A nurse independent prescriber"; (c) in sub-paragraph (a), omit "diazepam, lorazepam, midazolam,"; (d) in sub-paragraph (e), at the end insert "; and"; and (e) after sub-paragraph (e), insert—
Amendment of regulation 7 of the 2001 Regulations
(b) in paragraph (5)—
(ii) for "the extended formulary nurse prescriber" substitute "the nurse independent prescriber".
Amendment of regulation 8 of the 2001 Regulations
(b) in sub-paragraph (a), after "care" add "or treatment of tonic-clonic seizures".
Amendment of regulation 10 of the 2001 Regulations
(b) in sub-paragraph (a), for "extended formulary nurse prescriber", in both places those words appear, substitute "nurse independent prescriber".
(This note is not part of the Regulations) These Regulations amend the Misuse of Drugs Regulations 2001 ("the 2001 Regulations"). Regulations 2 to 7 amend regulations 2, 6B and 7 to 10 of the 2001 Regulations, to replace references to "extended formulary nurse prescribers" with references to "nurse independent prescribers". The effect is that nurse independent prescribers will be allowed to prescribe, supply, possess, administer and give directions for the administration of specified controlled drugs in those circumstances in which extended formulary nurse prescribers were previously able to. Regulations 3(c) to (e) and 6(b) amend regulations 6B and 9 of the 2001 Regulations to allow nurse independent prescribers to prescribe and supply diazepam, lorazepam and midazolam for the treatment of tonic-clonic seizures. Notes: [1] 1971 c.38. Section 22 of that Act was amended by section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979 (c. 2).back [2] S.I. 2001/3998; relevant amending instruments are S.I. 2003/2429 and 2005/2864.back [3] The definition of "extended formulary nurse prescriber" was inserted by S.I. 2003/2429 and substituted by S.I. 2005/2864.back [4] S.I. 1997/1830. The definition of nurse independent prescriber will be inserted into the 1997 Order by the Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2006 (S.I. 2006/915) and will come into force on 1st May 2006.back [5] The definition of "prescription" was amended to include a reference to "extended formulary nurse prescriber" by S.I. 2003/2429.back [6] Regulation 6B was inserted by S.I. 2005/2864.back [7] Regulation 7 has been amended; paragraphs (4) and (5) were inserted by S.I. 2003/2429 and substituted by S.I. 2005/2864.back [8] Regulation 8 has been amended; paragraph (7) was inserted by S.I. 2003/2429 and substituted by S.I. 2005/2864.back [9] Regulation 9 has been amended; paragraph (7) was inserted by S.I. 2003/2429 and substituted by S.I. 2005/2864.back [10] Regulation 10 has been amended; paragraph (2) was amended to include extended formulary nurse prescribers by S.I. 2003/2429.back
ISBN 0 11 074440 3
|
|
| ||
| We welcome your comments on this site | © Crown copyright 2006 | Prepared 5 April 2006 |